← Back to Clinical Trials
Recruiting NCT07090837

NCT07090837 Evaluating the Effectiveness and Implementation of Caregiver Support Initiatives for Caregivers of Older Patients in Singapore

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07090837
Status Recruiting
Phase —
Sponsor Tan Tock Seng Hospital
Condition Caregiver
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2025-05-08
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Caregiver Support ModelStandard caregiver support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2025-05-08 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

We are evaluating the caregiver support initiatives at a tertiary hospital in Singapore (Tan Tock Seng Hospital - TTSH) provided to caregivers caring for older patients. The evaluation will focus on 1) evaluating the process / delivery / implementation of these initiatives to caregivers and 2) the outcomes of caregivers and their care recipients after receiving these caregiver support services at TTSH. Research questions are as follows: Process evaluation: 1. How are the bundle(s) of caregiver support initiatives at TTSH delivered to caregivers? 2. What and how was impact achieved for these initiatives? Outcome evaluation: 3. Did caregivers (and patients) benefit from these support initiatives and how? 4. Which aspects of the caregiver support initiatives are most beneficial to caregivers (and patients)? Eligible caregivers will be invited to take part in the study and to complete 3 surveys and an optional interview over the period of their care recipients' hospital stay at TTSH, and 2 months after discharge. During their care recipients' stay, they may be introduced to any of the caregiver support initiatives, based on their needs. Caregivers enrolled in this study will take part in 3 surveys - 1 conducted at the beginning of care recipients' hospital stay, 1 conducted around the discharge period and 1 conducted one month after discharge. The aim of the surveys is to find out if caregivers have attended or used any of these services and whether they benefited from them.

Eligibility Criteria

Inclusion Criteria: * 21 years of age and above * Main or secondary caregiver of an older person receiving home-based care * Able to read and converse in English * Has a mobile smartphone and is able to navigate basic functionalities on mobile apps Exclusion Criteria: * Participants who are cognitively impaired * Unwilling to download and utilise app * Unable to read or converse in English comfortably

Contact & Investigator

Central Contact

George Glass

✉ glass_george_frederick@ttsh.com.sg

📞 +65 6903 5384

Frequently Asked Questions

Who can join the NCT07090837 clinical trial?

This trial is open to participants of all sexes, studying Caregiver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07090837 currently recruiting?

Yes, NCT07090837 is actively recruiting participants. Contact the research team at glass_george_frederick@ttsh.com.sg for enrollment information.

Where is the NCT07090837 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT07090837 clinical trial?

NCT07090837 is sponsored by Tan Tock Seng Hospital. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology